MDLN — Medline Inc. stock price, charts and financials

QT26Medline Inc.

Medline Inc. (NASDAQ: MDLN) is a Healthcare company in the Medical - Instruments & Supplies industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
33.67
-1.56-4.43%
MDLNQT26Medline Inc.·NASDAQ
33.67-4.43%
News
Down 4.4% — NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm (prnewswire.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E29.12EPS (ttm)1.21Insider Own49.37%Shs Outstand845.61MPerf Week-10.31%
Market Cap29.79BForward P/E21.81EPS next Y1.62Insider Trans-20.90%Shs Float540.04MPerf Month-13.76%
Enterprise Value40.19BPEG11.45EPS next Q-Inst Own-Short Float5.45%Perf Quarter-15.84%
Income995.01MP/S1.02EPS this Y26.44%Inst Trans-Short Ratio3.08Perf Half Y-23.74%
Sales29.14BP/B2.56EPS next Y5.60%ROA2.47%Short Interest29.45MPerf YTD-16.12%
Book/sh-P/C18.98EPS next 5Y11.13%ROE6.87%52W High48.63 -30.76%Perf Year-
Cash/sh-P/FCF19.53EPS past 3/5Y-ROIC5.01%52W Low31.37 7.34%Perf 3Y-
Dividend Est.-EV/EBITDA14.72Sales past 3/5Y9.85% -Gross Margin24.04%Volatility5.37% 4.26%Perf 5Y-
Dividend TTM-EV/Sales1.38EPS Y/Y TTM-20.39%Oper. Margin7.04%ATR (14)2.04Perf 10Y-
Dividend Ex-Date-Quick Ratio2.51Sales Y/Y TTM14.24%Profit Margin3.31%RSI (14)39.61Recom2.16
Dividend Gr. 3/5Y-Current Ratio4.41EPS Q/Q50.00%SMA20-9.52%Beta0.54Target Price46.33
Payout9.96%Debt/Eq1.12Sales Q/Q10.66%SMA50-7.53%Rel Volume0.83Prev Close35.23
Employees45,000LT Debt/Eq0.65EarningsNov 04SMA200-15.69%Avg Volume9.91MPrice33.67
IPO DateDec 17, 2025Option/ShortYes / YesEPS/Sales Surpr.11.80% 2.64%Net Debt/EBITDA3.81Volume8,254,886Change-4.43%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedRobert W. Baird$45$42
Aug-06-26ReiteratedEvercore ISIOutperform$48$39
Aug-06-26ReiteratedStifel Nicolaus$50$45
Aug-06-26ReiteratedBMO CapitalOutperform$54$47
Aug-06-26ReiteratedRBC CapitalOutperform$53$46
Aug-06-26ReiteratedDeutsche Bank$42$37
Jun-03-26ReiteratedRobert W. Baird$57$45
Jun-01-26ReiteratedBarclaysOverweight$50$45
May-07-26ReiteratedDeutsche Bank$48$42
Mar-09-26ReiteratedTigress FinancialBuy$55$60
Latest News
Aug-07-26
Aug-06-26
Aug-05-26
Aug-03-26
Jul-31-26
Jul-29-26
Jul-27-26
Company

Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue29,14028,43225,507
Cost of Goods Sold Incl. D&A22,13420,91419,216
Gross Profit7,0067,5186,291
Selling, General and Administrative Excl. Other4,6954,5244,041
Research and Development0067
Other Operating Expense261782-42
Operating Income2,0502,2122,225
Interest Expense7928121,309
Unusual Expense
Non-Operating Income (Expense)-57-152330
Net Income Before Taxes1,2011,2481,246
Income Taxes1279146
Consolidated Net Income9641,1591,200
Net Income From Continuing Operations1,0741,1571,200
Net Income9641,1591,200
EPS (Recurring)1.211.431.52
EPS (Basic, Before Extraordinaries)1.211.431.52
EPS (Diluted)1.211.431.52
EBITDA2,7311,9523,532
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio27.8329.37
Price To Sales Ratio0.951.20
Gross Margin24.0426.4424.66
Operating Margin7.047.788.72
Net Margin3.314.084.70
Shares Outstanding819812787
Market Capitalization27,57634,104
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$52.51$47.05$41.59$36.13$30.67 Close Price0.00M549.65M1099.30M1648.96M2198.61MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BCP 8 Holdings Mozart Manager L.L.C.10% OwnerMay 28 '26Sale36.5433,317,8241,217,349,9941,539Jun 01
Carlyle Group Inc.10% OwnerMar 10 '26Sale41.0026,105,8401,070,339,440127,567,724Mar 12
BCP 8 Holdings Mozart Manager L.L.C.10% OwnerMar 10 '26Sale40.5127,852,9861,128,268,7561,539Mar 12
Mozart Aggregator II LP10% OwnerDec 18 '25Sale18.7120,417,040381,911,07672,372,632Dec 22
Carlyle Group Inc.10% OwnerDec 18 '25Sale29.0019,136,333554,953,657145,924,924Dec 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.